Naproxen Tablet, Delayed Release
Product Images NDC 69097-852

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 69097-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

375mg 100tab

375mg 100tab
Each tablet contains 375mg of naproxen, USP. The usual dosage can be found in the package insert. The package is child-resistant and should be stored at 20-25°C. The tablets are manufactured by Cipla USA, Inc. and InvaGen Pharmaceuticals, Inc. This product is only available by prescription.*
FDA Label Image

500mg 100tab

500mg 100tab
Naproxen is a medication that comes in delayed-release tablets of 500mg. The usual dose is indicated in the package insert. The package is child-resistant, and it is advised to store it in light-resistant containers at temperatures between 20-25°C. The medication guide needs to be dispensed separately to each patient. It is manufactured by InvaGen Pharmaceuticals Inc, a subsidiary of Cipla Ltd. If the text is illegible, please check again.*
FDA Label Image

Naproxen Structure

Naproxen   Structure
This text provides chemical information on the drug Naproxen, which has a molecular formula of C14H14O3 and a molecular weight of 230.26. The text seems to refer to specific chemical structures or reactions, but without more information, it is difficult to interpret the meaning of the "CHy0" and "CH3" text.*
FDA Label Image

Naproxen Table

Naproxen   Table
This is a description of the pharmacokinetic properties of two different forms of Naproxen tablets. The two forms are delayed-release tablets and regular Naproxen tablets, both taken at a dose of 500mg twice daily. The table shows the maximum concentration (Cmax), time to reach maximum concentration (Tmax), and the area under the curve for a 12-hour period (AUCG-12 hr) for both forms of the drug. The values are presented as mean values with the coefficient of variation in parentheses.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.